Urea (13C)
Brand names: Diabact UBT, Helicobacter Test INFAI
Urea labelled with the stable carbon-13 isotope is a diagnostic agent used in the urea breath test to detect Helicobacter pylori infection in the stomach.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
If H. pylori is present, its urease enzyme hydrolyses the ingested labelled urea into ammonia and labelled carbon dioxide, which is absorbed and exhaled and then measured in breath samples.
Prescribing in practice
- The test can give false-negative results if the patient has recently taken proton pump inhibitors, antibiotics or bismuth, so these should be stopped for the recommended washout period beforehand.
- It is taken after fasting, usually with a citric acid drink to delay gastric emptying and improve test performance.
- It is a purely diagnostic, non-radioactive agent suitable for confirming eradication after treatment as well as initial diagnosis.
Monitoring
No drug monitoring is required; the test outcome is determined by comparing labelled carbon dioxide in pre- and post-dose breath samples.
Counselling the patient
- Avoid eating before the test and follow the fasting instructions you are given.
- Tell the team if you have recently taken acid-suppressing medicines or antibiotics, as these can affect the result.
Evidence & guidelines
The carbon-13 urea breath test is endorsed by NICE as a non-invasive method for diagnosing H. pylori and confirming eradication.
Reference: NICE CG184; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Duke Treadmill Score · Coronary Artery Disease
- Pre-test Probability for Stable CAD (ESC 2019) · Chest Pain
- Thyroid Function Test Interpretation · Thyroid Disease
- Dix-Hallpike Test Interpretation / BPPV Assessment · Vestibular
- Snellen Visual Acuity Interpretation · Ophthalmology
- Ishihara Colour Vision Test Interpretation · Ophthalmology
- Lower Gastrointestinal Bleed · BSG 2019; NICE NG141
- Variceal Upper GI Bleed · BSG 2015; Baveno VII (2022)
- Spontaneous Bacterial Peritonitis (SBP) · BSG / EASL 2018
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Hepatic Encephalopathy · EASL 2014; West Haven criteria
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021